Tg Therapeutics Inc (TGTX)

EBITDA Margin

16.79%

TTM · Period ending:

TGTX logo

TGTX EBITDA Margin

Latest reported16.79%
TGTX EBITDA Margin (-3700.00% → 16.79%)
High-resolution chart · PNG

TGTX ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
21.8017%
15.1676%
11.17%
-7,651.921%
-5,112.4084%
-179,393.4211%
-110,067.1053%
-114,075%
-77,695.8151%
-51,782.0463%
-41,451.7322%
-36,564.3755%
-12,812.7516%
-130,968.9994%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-199.0922%
-112.1402%
-57.5934%
-216.6667%
-100%
-5,200%
-3,700%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.